Ernexa Therapeutics revenue ERNA

Sales by quarter and over the last twelve months, from 2010.

Ernexa Therapeutics' revenue was $582K over the twelve months to Dec 31, 2024.

In its latest quarter, Q4 FY24, it was $1K, down 94% on the same quarter a year before.

Over the five fiscal years to FY2024 it shrank 52% a year on average.

Revenue over time

Each fiscal year is the twelve months to its fourth quarter.

Quarter	Ended	Revenue	On a year earlier	Last 12 months
Q4 FY24	Dec 31, 2024	$1K	−94%	$582K
Q3 FY24	Sep 30, 2024	$487K	+855%	$598K
Q2 FY24	Jun 30, 2024	$47K	n/a	$162K
Q1 FY24	Mar 31, 2024	$47K	n/a	n/a
Q4 FY23	Dec 31, 2023	$17K	n/a	n/a
Q3 FY23	Sep 30, 2023	$51K	n/a	n/a
Q1 FY23	Mar 31, 2023	$0	n/a	n/a
Q4 FY22	Dec 31, 2022	$0	n/a	n/a
Q3 FY22	Sep 30, 2022	$0	n/a	n/a
Q4 FY20	Dec 31, 2020	$1.2M	−77%	$5.8M
Q3 FY20	Sep 30, 2020	$1.5M	−68%	$9.8M
Q2 FY20	Jun 30, 2020	$754K	−86%	$12.9M

Companies in Healthcare nearest Ernexa Therapeutics' size, closest first, today.

Company	Revenue, 12 months	Growth
ERNAErnexa Therapeutics	n/m
OXBROXBRIDGE RE HOLDINGS	$2.8M	+40% a year
EDUCEducational Development	$20M	−32% a year
GTIMGood Times Restaurants	$135.1M	−6% a year
MDRRMedalist Diversified	$9.6M	−1% a year
BCGBinah Capital	$191.9M	+8% a year
VIPVulcan Infrastructure & Power	$50.9M	−14% a year
MXCMexco Energy	$6.7M	−9% a year
CKXCKX Lands	$693.4K	−17% a year
MSGMMotorsport Games	$14.5M	+79% a year
ATCHAtlasClear	$20.1M	+85% a year
Peer median	$17.3M